Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to… Read More
Experimental compounds that alter RNA boost the effectiveness of immunotherapy drugs against cancer cells and could potentially extend their use… Read More
New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. It’s currently developing preclinical therapies that… Read More